The $100m Longevity Investment Raises by Juvenescence is a Major Milestone

The $100 million investment in longevity by Juvenescence is raised again

UK biotech is valued at $500m, and aims to IPO in next year.

Source:
https://www.ft.com/content/ddec6a10-c046-11e9-b350-db00d509634e

Leave a Reply

Your email address will not be published. Required fields are marked *